Original Query: ALL
Previous Study | Return to List | Next Study

Study of Carboplatin/Gemcitabine Plus Bevacizumab in Advanced Lung Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00150657
Recruitment Status : Unknown
Verified September 2005 by St. John Providence Health System.
Recruitment status was:  Recruiting
First Posted : September 8, 2005
Last Update Posted : November 29, 2005
Genentech, Inc.
Eli Lilly and Company
Information provided by:
St. John Providence Health System

No Study Results Posted on for this Study
  Recruitment Status : Unknown
  Primary Completion Date : No date given
  Study Completion Date : No date given